Morning Overview on MSN
FDA pilots AI and real-time data reviews to speed some clinical trials
A cancer patient enrolled in a clinical trial today might wait months before regulators ever see the safety data generated by ...
The US Food and Drug Administration plans to cut the time it takes drug companies to test new medicines by getting more ...
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with ...
FDA-regulator access to near real-time safety and endpoint streams is intended to enable earlier signal detection and more ...
Payer-provider clinical data exchange plays a critical role in payer operations, helping streamline workflows and improve patient care. Traditionally, this exchange ...
MedPage Today on MSNOpinion
Real-Time Trial Review Needs a Response Plan, Not Just a Data Feed
Three recommendations for response-side standards before the pilot is scaled ...
Boosting real-time data and analytics capabilities is a top priority for business leaders looking to gain competitive advantage through faster insights and decision-making. However, many organizations ...
Time has always mattered on the trading floor. A delay of a few seconds could cost millions. Now, with the emergence of generative AI (gen AI), it’s the power of real-time that matters most. Together, ...
Researchers and scientists are turning to artificial intelligence (AI) as a potentially powerful tool in the fight to slow the pace of climate change. The Fast Company Executive Board is a private, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results